ESMO scientific and educational resources on this topic
Recent medwireNews, books and resources from conferences are for ESMO Members only.
Tumour Sites: Head and Neck Cancers
Head & Neck Cancers
Latest ESMO videos
Featured medwireNews
First-Line Toripalimab Boosts Advanced Nasopharyngeal Carcinoma Survival
Treatment Beyond Progression Benefit Reported For CheckMate 141 Study
Induction Chemotherapy Boosts Nasopharyngeal Carcinoma Response
Cetuximab Regimen Inferior To Cisplatin For HPV-Positive Oropharyngeal Carcinoma
First-Line Pembrolizumab Plus Platinum-Based Chemotherapy ‘Standard Of Care’ For Advanced HNSCC
E-Learning
ESMO E-Learning: HPV-Related Cancers: Prevention, Vaccines and Treatment
ESMO E-Learning: Multimodular Treatment in Head and Neck Squamous Cell Carcinoma (HNSCC)
Factsheets on Biomarkers
PD-L1 in Cancer: ESMO Biomarker Factsheet
Meeting resources
Presentation
Presenter: Christina Yap
Session: How to write a grant
Resources:
Slides
Webcast
Participant Clinical Case Discussion: HPV associated Head & Neck Cancer
Presenter: E. Kale, ZA
Session: Session 3 - Development in Radiotherapy
Resources:
Slides
Current Advances in HPV associated Head & Neck Cancers
Presenter: S. Oosting, KL
Session: Session 3 - Development in Radiotherapy
Resources:
Slides
Webcast
121O - RATIONALE 309: A randomized, global, double-blind, Phase 3 trial of tislelizumab (TIS) vs placebo, plus gemcitabine + cisplatin (GP), as 1L treatment for recurrent/metastatic nasopharyngeal cancer (RM-NPC)
Presenter: Yunpeng Yang
Session: Proffered Paper session 2
Resources:
Abstract
Slides
Webcast
Targeting cancer-associated fibroblasts to enhance immune responses in H&N cancer
Presenter: Erik Sahai
Session: New indications in head and neck (H&N) cancer (incl anaplastic thyroid)
Resources:
Slides